CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
0.285 |
Evidence |
|
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
CCRL1 |
CCRL1, CCBP2, CCR11, VSHK1: C-C chemokine receptor type 11 |
0.285 |
Evidence |
|
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR2B2 |
OR2B2, OR2B9: Olfactory receptor 2B2 |
0.285 |
Evidence |
|
GPR4 |
GPR4, GPR19: Probable G-protein coupled receptor 4 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.285 |
Evidence |
|
OR7C1 |
OR7C1, OR7C4: Olfactory receptor 7C1 |
CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
0.285 |
Evidence |
|
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.285 |
Evidence |
|
MAS1 |
MAS1, MAS: MAS proto-oncogene |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.285 |
Evidence |
|
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
CNR2 |
CNR2: Cannabinoid receptor 2 |
0.285 |
Evidence |
|
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
SSTR4 |
SSTR4: Somatostatin receptor type 4 |
0.285 |
Evidence |
|
ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
EDG2 |
EDG2, LPA1: Lysophosphatidic acid receptor Edg-2 |
0.285 |
Evidence |
|
CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
GPR88 |
GPR88, STRG: Probable G-protein coupled receptor 88 |
0.285 |
Evidence |
|
CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
CCR4 |
CCR4, CMKBR4: C-C chemokine receptor type 4 |
0.285 |
Evidence |
|
GNAI2 |
Galphai2 protein |
RGS1 |
RGS1, 1R20, BL34, IER1: Regulator of G-protein signaling 1 |
0.285 |
Evidence |
|
CXCL2 |
CXCL2, GRO2, GROB, MIP2A, SCYB2: Macrophage inflammatory protein 2-alpha precurs |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.285 |
Evidence |
|
TNFRSF13B |
TNFRSF13B, TACI: Tumor necrosis factor receptor superfamily member 13B |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
0.285 |
Evidence |
|
SSTR4 |
SSTR4: Somatostatin receptor type 4 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.285 |
Evidence |
|
PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
P2RY5 |
P2RY5: P2Y purinoceptor 5 |
0.285 |
Evidence |
|
OR2B2 |
OR2B2, OR2B9: Olfactory receptor 2B2 |
CCL27 |
CCL27, ILC, SCYA27: Small-inducible cytokine A27 precursor |
0.285 |
Evidence |
|
CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
GPR45 |
High-affinity lysophosphatidic acid receptor homolog |
0.285 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
STYK1 |
STYK1, NOK: Tyrosine protein-kinase STYK1 |
0.285 |
Evidence |
|
OMG |
OMG, OMGP: Oligodendrocyte-myelin glycoprotein precursor |
ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
0.285 |
Evidence |
|
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
TBXA2R |
TBXA2R: TBXA2R protein |
0.285 |
Evidence |
|
CCR9 |
IPI00019986 |
CCL18 |
CCL18, AMAC1, DCCK1, MIP4, PARC, SCYA18: Small-inducible cytokine A18 precursor |
0.285 |
Evidence |
|
BMP10 |
BMP10: Bone morphogenetic protein 10 precursor |
ACVR2B |
ACVR2B: Activin receptor type-2B precursor |
0.285 |
Evidence |
|